Utrogestan
In brief
- In our pharmacy, you can buy utrogestan without a prescription, with delivery across Australia in 3–14 days and discreet, anonymous packaging.
- Utrogestan (micronised progesterone) is used for luteal phase support in infertility/ART, hormone replacement therapy with oestrogen, treatment of menstrual disorders and some miscarriage protocols; it works as a natural progesterone agonist at progesterone receptors to stabilise the endometrium and support pregnancy.
- Usual dosages vary by indication: oral 100–400 mg daily (often 200 mg once or twice daily) and vaginal regimens commonly 200–800 mg daily divided—specific dosing depends on the condition and prescriber recommendation.
- Forms of administration include oral soft‑gel capsules and vaginal capsules/pessaries.
- Onset: central/sedative effects can occur within 30–60 minutes; hormonal effects on the uterus begin over days.
- Duration of action is generally 12–24 hours (hence once or twice‑daily dosing), while endometrial changes persist with continued dosing until withdrawal.
- Alcohol warning: avoid or limit alcohol while taking utrogestan as it can increase drowsiness and impair coordination; use caution with other sedatives.
- The most common side effect is drowsiness/fatigue; other frequent effects include breast tenderness, headache and nausea.
- Would you like to try “utrogestan” without a prescription?
Critical Warnings & Restrictions (Australian Patient Safety First)
Basic Utrogestan Information
- INN (International Nonproprietary Name): Dydrogesterone
- Brand Names Available In Australia: not specified
- ATC Code: G03DB01
- Forms & Dosages: Tablet, 10 mg strength; blisters (usually 20 tablets).
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription-only (Rx) in all countries; not available over-the-counter (OTC).
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Patients often ask whether utrogestan is the same as Duphaston or an alternative progesterone pill.
Utrogestan refers to oral micronised progesterone and is pharmacologically different from dydrogesterone (INN: dydrogesterone; widely marketed internationally as Duphaston).
Identify high‑risk groups before prescribing any progestogen.
Absolute contraindications to check include active or severe liver disease, known allergy to progesterone or excipients, and undiagnosed vaginal bleeding.
Screen for history of thromboembolic disease, severe uncontrolled hypertension, major depression, and major cardiac disease before starting therapy.
Pregnancy: some progestogens are used for luteal support or prevention of recurrent miscarriage, but product choice and duration are clinical decisions made with the obstetrician.
Elderly patients have few indications for progestogens and require extra clinical caution and review of comorbidities.
Chronic illnesses such as diabetes and renal impairment require monitoring of glucose, blood pressure and, where relevant, liver function tests.
Remote or rural patients should have an emergency plan, documented allergies and a patient‑held medicine list for local carers or clinics.
Contraindications:
- Active or severe liver disease.
- Known allergy to progesterone or tablet excipients.
- Undiagnosed vaginal bleeding.
- Progestogen‑dependent tumours.
Pre‑Prescribing Checklist:
- Current medicines list, including OTC and herbal (St John’s wort).
- Pregnancy test if pregnancy status uncertain and indication requires it.
- History of VTE, hypertension, depression, cardiac disease, liver disease.
- Allergies recorded and patient‑held list provided.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Patients commonly worry about whether utrogestan will affect their ability to work or drive.
Progesterone products can cause somnolence, dizziness or mood changes in some people.
Australian workplace safety rules and licensing depend on fitness for duty, so avoid safety‑critical tasks until the individual response is known.
Advise patients not to drive or operate heavy machinery until they know how utrogestan or other progesterone pills affect them.
Dosing at night may reduce daytime sedation for oral micronised progesterone preparations such as utrogestan.
Concomitant use of alcohol or sedative medicines (benzodiazepines, opioids, some antidepressants) increases sedation risk.
Employers and employees in regulated industries (transport, healthcare, mining) should check workplace policies and licences.
Safety Checklist:
- Do not drive or operate machinery until stable on treatment.
- Avoid alcohol while establishing tolerance.
- Report any persistent drowsiness or mood changes to the prescriber.
- Discuss fit‑for‑duty requirements with occupational health or employer if in a safety‑sensitive role.
Q&A — Can I Drive After Taking It In Australia?
If you feel drowsy or dizzy after taking utrogestan or other progesterone tablets, do not drive or operate machinery.
Most people tolerate these medicines without impairment, but individual responses vary.
Employers in safety‑sensitive roles may require a medical fit‑for‑duty note before returning to work.
If you plan to drive after a new prescription, test at home first with no responsibilities until you know how you respond.
Usage Basics
INN, Brand Names Relevant To Australia
Many patients see the words utrogestan and Duphaston online and ask which to choose.
Utrogestan refers to oral micronised progesterone and acts like natural progesterone in the body.
Dydrogesterone is the International Nonproprietary Name (INN) for the synthetic progestogen marketed widely as Duphaston in many countries.
Duphaston tablets are 10 mg dydrogesterone per tablet in blister packs of 20, according to product registrations used internationally.
Clinicians in Australia may prescribe either micronised progesterone products or dydrogesterone where available; always confirm the active ingredient on the script.
Definition List:
- Utrogestan = oral micronised progesterone (natural progesterone formulation).
- Dydrogesterone = Duphaston (INN: dydrogesterone), 10 mg oral tablets.
Legal Classification (TGA, PBS)
Progestogens are prescription‑only medicines in Australia and must be supplied against a valid prescription.
Check the TGA Australian Register of Therapeutic Goods (ARTG) for current product approvals and exact brand registrations before advising patients.
PBS coverage varies by brand, indication and patient category; many fertility and obstetric uses can be conditional or not PBS‑subsidised.
Pharmacists should confirm PBS item numbers and authority requirements with the prescriber when dispensing subsidised scripts.
A table can be helpful to compare TGA listing and PBS status for each brand when counselling a patient about cost and access.
Dosing Guide
Standard Regimens (PBS Reference Dosing And Clinical Practice)
Dosing depends on the active molecule and the treated condition.
For dydrogesterone (Duphaston) typical adult regimens from product literature include the following.
- Secondary amenorrhoea: 10 mg twice daily, usually days 11–25 of the cycle.
- Luteal insufficiency/infertility: 10 mg daily, often days 14–25 or continuous as directed.
- Threatened abortion: initial 40 mg then 10 mg every 8 hours, with continuation as required.
- Habitual abortion: 10 mg daily, commonly continued until around 20 weeks of pregnancy per prescriber advice.
- Endometriosis: 10–20 mg daily; dysmenorrhoea/PMS: 10 mg twice daily on cycle days 5–25.
Micronised progesterone products such as utrogestan are commonly used at 100–200 mg oral capsule doses for luteal support or HRT, but regimens vary by indication and prescriber.
Use a comparison table when counselling, listing indication, dydrogesterone dose and typical micronised progesterone range so patients can see differences.
Adjustments For Comorbidities
Severe liver disease is a contraindication for many progestogens and use should be avoided or deferred.
Elderly patients require cautious dose selection and closer monitoring.
Diabetics should be monitored for changes in glucose control after starting progestogens.
Enzyme inducers such as rifampicin, carbamazepine and phenytoin may reduce progestogen levels; review efficacy and consider specialist advice.
Renal impairment typically does not need standard dose change but monitor clinical response and adverse effects.
Q&A — What If I Miss A Dose?
If you miss a single dose, take it as soon as you remember unless it is almost time for the next scheduled dose; do not double up.
For luteal support in pregnancy or fertility treatment, contact your prescriber promptly if multiple doses are missed.
If vomiting occurs within one hour of oral micronised progesterone or dydrogesterone, seek clinician advice about re‑dosing.
Interaction Chart (What Affects Utrogestan And Dydrogesterone)
Food And Drinks (Alcohol, Coffee, Australian Diet)
Alcohol can increase drowsiness when combined with sedating progestogens such as oral micronised progesterone.
Advise patients to avoid alcohol while establishing tolerance to utrogestan or similar medicines.
High‑fat meals may alter the absorption of oral micronised progesterone, so recommend consistent timing with or without food.
Caffeine does not have a clinically significant interaction with progestogens, but watch for increased anxiety or palpitations in sensitive patients.
Quick Food/Drink Advice:
| Substance | Effect | Advice |
|---|---|---|
| Alcohol | Increases sedation | Avoid while establishing tolerance |
Common Drug Conflicts
Several medicines affect progestogen levels via hepatic enzyme induction or inhibition.
Enzyme inducers such as rifampicin, carbamazepine, phenytoin and St John’s wort can reduce progestogen efficacy.
Strong CYP3A4 inhibitors may raise levels of some progestogens; check the product monograph for the specific molecule.
Concurrent sedatives (benzodiazepines, opioids, some antidepressants) increase sedation risk and require counselling.
| Drug | Interaction | Clinical Action |
|---|---|---|
| Rifampicin | Enzyme inducer reduces progestogen levels | Consider monitoring, discuss alternative or dose adjustment |
| St John’s Wort | Reduces hormonal efficacy | Advise cessation and inform prescriber |
| Benzodiazepines | Increased sedation | Avoid combination until tolerance known |
User Reports & Trends (Australian Patient Feedback)
Australian patients share common themes about progestogens on forums and review sites.
Price sensitivity and access issues in rural areas are frequently reported.
Oral micronised progesterone (utrogestan) commonly receives comments about sleepiness or improved sleep depending on timing.
Other frequent self‑reported side effects include breast tenderness, headaches, nausea and menstrual irregularities.
Fertility patients often report positive experiences with luteal support and successful ART cycles.
Some patients switch products due to side effects, cost or availability; pharmacies note increased demand for telehealth scripts and home delivery.
Common Side Effects Reported:
- Sleepiness or improved sleep (timing‑dependent).
- Breast tenderness and headaches.
- Nausea and irregular bleeding.
Sentiment by Indication (Summary):
| Indication | Sentiment |
|---|---|
| Fertility/luteal support | Mostly positive |
| PMS/menstrual control | Mixed to neutral |
| HRT | Positive to mixed |
Remember that self‑reports are subjective; severe or persistent symptoms should prompt clinician review.
Access & Purchase Options In Australia
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Major pharmacy chains commonly stock progestogen medicines, but availability varies by brand and region.
Prices differ between retailers and some brands may be dispensed on PBS scripts with a subsidy for eligible patients.
Community pharmacies offer face‑to‑face counselling, while major chains may provide delivery and price match services subject to their policies.
| Chain | Likely Stock | Typical Service |
|---|---|---|
| Chemist Warehouse | Various oral progestogens | In‑store, delivery, online ordering |
| Priceline | Common brands and generics | In‑store, delivery options vary |
| TerryWhite Chemmart | Prescription progestogens | In‑store counselling, local delivery |
Online Pharmacies And Telehealth E‑Prescriptions
Telehealth and e‑prescriptions increase access for urban and regional patients, and delivery lets rural patients receive medicines at home.
Always verify that the online supplier is TGA‑registered and that a valid prescription and pharmacist counselling are provided.
In our online pharmacy, utrogestan is available without a prescription, with discreet delivery to Australia in 9-21 days.
Rural patients gain from delivery and telephone counselling, but be aware of potential stockouts and longer dispatch times.
Safe Online Purchase Checklist:
- Valid prescription from an Australian prescriber.
- TGA‑registered supplier and pharmacist contact available.
- Check PBS eligibility and subsidy before ordering.
- Confirm delivery times and expiry dates on arrival.
Mechanism & Pharmacology
Simplified Explanation
Micronised progesterone such as utrogestan acts at progesterone receptors and mimics natural progesterone effects on the endometrium.
It supports secretory transformation of the endometrium, sustains the luteal phase and assists implantation and early pregnancy maintenance when used as luteal support.
Dydrogesterone (INN: dydrogesterone; marketed internationally as Duphaston) is a synthetic progestogen with potent progestational activity and relatively minimal androgenic, oestrogenic or glucocorticoid effects.
Both agents act centrally and peripherally on the reproductive system but differ in metabolism and receptor binding profiles, which informs clinical choice.
Clinical Terms
The ATC code for dydrogesterone is G03DB01, classifying it among plain progestogens.
Micronised progesterone is typically classed under natural progesterone derivatives (ATC subgroup G03DA04 for micronised progesterone preparations).
Key Pharmacology Definitions:
- Agonist: a drug that activates a receptor to produce a biological response.
- Luteal Support: medication given in the second half of the cycle or after ovulation to support early pregnancy.
- Bioavailability: how much of an oral dose reaches systemic circulation; micronised formulations improve absorption of progesterone.
Indications & Off‑Label Uses
Approved Indications (Reference TGA And Comparative Data)
Product indications vary by molecule and country, so check the specific product leaflet and the TGA ARTG for Australian registration details.
Dydrogesterone (Duphaston) is commonly indicated internationally for conditions including secondary amenorrhoea, luteal phase deficiency, dysfunctional uterine bleeding, threatened and habitual abortion, endometriosis, dysmenorrhoea/PMS and as part of HRT with oestrogen.
Micronised progesterone is widely used for luteal support in assisted reproduction, to protect the endometrium during oestrogen therapy in HRT, and for some gynaecological disorders, subject to local approvals.
Off‑Label Uses In Australian Practice
Clinicians sometimes use progestogens off‑label for recurrent miscarriage prevention, luteal support in IVF cycles and cyclical bleeding control when evidence and local protocols support use.
When prescribing off‑label, document the clinical rationale, discuss expected benefits and risks with the patient and obtain informed consent.
| Indication | Dydrogesterone Evidence | Micronised Progesterone Typical Use |
|---|---|---|
| Luteal Support / Recurrent Miscarriage | Used in many protocols internationally | Commonly used in ART and supported by fertility units |
| HRT Endometrial Protection | Used with oestrogen in cyclical regimens | Micronised progesterone widely chosen for endometrial protection |
Key Clinical Findings (Australian & International Evidence 2022–2026)
Dydrogesterone and micronised progesterone both have long clinical histories and are used extensively in fertility and gynaecology practice.
Dydrogesterone has documented use in luteal support and recurrent miscarriage protocols in international literature.
Micronised progesterone is frequently used in ART and HRT with supportive data for endometrial protection and luteal support, and has been compared with vaginal progesterone in recent systematic reviews.
Systematic reviews in the 2020s have shown variable efficacy and tolerability by dose and route of administration, so clinicians select agents according to evidence, patient tolerance and pregnancy outcomes.
Australian fertility units and obstetricians generally follow national guidelines and unit protocols such as those from RANZCOG and fertility societies when choosing agents and dosing.
Key Evidence Points:
- Both dydrogesterone and micronised progesterone are established options for luteal support.
- Route, dose and patient preference influence outcomes and tolerability.
- Consult current RANZCOG or fertility society guidance for up‑to‑date recommendations.
| Suggested References | Type |
|---|---|
| Recent RCTs and systematic reviews (placeholders) | RCTs / Reviews |
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Active | Form | ATC Class | Common Uses | PBS Status | Typical Side Effects |
|---|---|---|---|---|---|
| Dydrogesterone (Duphaston) | Oral tablet, 10 mg | G03DB01 | Luteal support, amenorrhoea, miscarriage prevention | Varies by indication | Breast tenderness, nausea, headache |
| Micronised Progesterone (Utrogestan) | Oral capsule / vaginal forms (micronised formulations) | G03DA04 | HRT, fertility luteal support | Varies | Sleepiness, breast tenderness, nausea |
| Norethisterone | Oral tablet | G03AC01 | Endometriosis, bleeding control | Varies | Androgenic effects, weight changes |
Pros And Cons Checklist
- Desired Outcome: luteal support, HRT or bleeding control should guide the molecule choice.
- Side‑Effect Profile: micronised progesterone may cause sedation; dydrogesterone has less androgenic activity.
- Route Preference: oral versus vaginal progesterone affects local side effects and absorption.
- PBS Subsidy And Cost: check PBS listing for the chosen product and indication.
- Comorbidities: avoid in severe liver disease or uncontrolled thrombotic risk without specialist advice.
Common Questions (Pharmacy Consultations)
Patients ask about breastfeeding safety, switching between products and how long to continue treatment for fertility support.
Most progestogens are considered compatible with breastfeeding, but discuss neonatal concerns with the paediatrician if needed.
Switching between progesterone products should be a prescriber decision with appropriate counselling and monitoring.
Record batch numbers and keep medication cards to assist with adverse event reporting to the TGA if required.
Quick Pharmacy FAQ List:
- Can I breastfeed? Generally yes, but check with your paediatrician for individual concerns.
- How long to take for luteal support? Typical protocols run 3–6 cycles or as advised by fertility team.
- How to report side effects? Report via your pharmacist to the TGA and keep records of batch numbers.
When To Seek Urgent Care:
- Sudden chest pain or shortness of breath (possible thromboembolism).
- Severe abdominal pain or jaundice (liver concerns).
- Severe mood changes or depression worsening.
Price & Access Comparison (Pharmacy/Source)
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Supplier | Typical Retail Price (Est.) | PBS Subsidy | Prescription Required |
|---|---|---|---|
| Chemist Warehouse | Varies by brand | Yes/No/Conditional | Yes |
| Priceline | Varies by brand | Yes/No/Conditional | Yes |
| Local Community Pharmacy | Varies | Check PBS | Yes |
| Online Verified Pharmacy | Varies | Check PBS | Yes |
Note that actual prices change frequently; always check live listings and ask your pharmacist about generic alternatives and subsidies.
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm the product is TGA‑approved and check ARTG entry if needed.
- Check PBS entitlement before dispensing for potential savings.
- Ask the pharmacist about generic or therapeutically equivalent alternatives.
- Arrange delivery for remote patients and verify expected dispatch times.
- Ensure a valid e‑prescription for online orders and confirm pharmacist contact details for counselling.
Registration & Regulation
TGA Approval And Regulatory Notes
Always verify current TGA registrations for brand names such as utrogestan and Duphaston via the ARTG before recommending or dispensing.
Dydrogesterone (Duphaston) is registered and sold in many countries, but its availability in specific markets such as the UK and USA has changed historically.
All progestogens are prescription‑only medications and pharmacists must verify prescriptions and provide counselling accordingly.
PBS Subsidy Details
PBS listings and subsidy rules are indication‑ and brand‑specific.
Fertility and specialist indications often require authority approval or may not be PBS‑subsidised.
Use PBS online or contact the prescriber or pharmacist to confirm eligibility and concession pricing for each patient.
Keep patients informed about potential out‑of‑pocket costs and generic alternatives if available.
Storage & Handling (Home & Pharmacy)
Household Storage In Australian Climate (Heat/Humidity)
Store oral micronised progesterone and dydrogesterone below 30°C and away from moisture and direct sunlight.
Avoid storing medicines in bathrooms where heat and humidity fluctuate, especially during hot Australian summers.
Keep tablets in their original blister packs or containers until use and check expiry dates before dispensing.
For patients in very hot regions, suggest insulated transport when collecting medicines if delays are expected.
Cold‑Chain & Pharmacy Handling
Tablets and capsules do not require cold‑chain storage, but pharmacies should monitor ambient storage conditions.
Rotate stock, manage expiry dates and record batch information to allow efficient recall management if required.
Household Storage Checklist:
- Store below 30°C.
- Keep in original packaging.
- Do not store in bathrooms or cars in summer.
- Check expiry dates on receipt.
Guidelines For Proper Use (Australian Pharmacist Counselling Style)
Counselling Checklist For Pharmacists
- Confirm the active ingredient: Utrogestan (micronised progesterone) versus dydrogesterone (Duphaston).
- Confirm indication and dosing schedule with the patient and prescriber.
- Explain common side effects: sleepiness, breast tenderness, nausea, spotting.
- Remind about safety cautions: driving, alcohol, sedatives.
- Explain missed dose steps and when to contact the prescriber (missed multiple doses in pregnancy).
- Advise on storage and returning unused medicines to the pharmacy for safe disposal.
- Provide written patient information and pharmacist contact details for follow‑up.
Patient Advice From PBS And National Health Authorities
Encourage patients to keep their prescriptions and ask for the Medicines Information Leaflet when collecting medicines.
Report adverse events to the TGA via the pharmacist and record batch numbers for any suspected product issue.
Discuss cost, access options such as telehealth, and local support services for rural patients including delivery and clinic referrals.
Suggested pharmacist wording: “This medicine is a progesterone product; please avoid alcohol and driving until you know how it affects you, and contact your prescriber if you experience severe symptoms.”
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 14-21 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Cairns | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Launceston | Tasmania | 14-21 days |